title: Chronic injection of pansomatostatin agonist ODT8-SST differentially modulates food intake and decreases body weight gain in lean and diet-induced obese rats.
abstract: The aim of this study was to investigate the central actions of the stable pansomatostatin peptide agonist, ODT8-SST on body weight. ODT8-SST or vehicle was acutely (1μg/rat) injected or chronically infused (5μg/rat/d, 14d) intracerebroventricularly and daily food intake, body weight and composition were monitored. In lean rats, neither acute nor chronic ODT8-SST influenced daily food intake while body weight was reduced by 2.2% after acute injection and there was a 14g reduction of body weight gain after 14d compared to vehicle (p<0.01). In diet-induced obese (DIO) rats, chronic ODT8-SST increased cumulative 2-week food intake compared to vehicle (+14%, p<0.05) and also blunted body weight change (-11g, p<0.05). ODT8-SST for 14d reduced lean mass (-22g and -25g respectively, p<0.001) and total water (-19g and -22g respectively, p<0.001) in lean and DIO rats and increased fat mass in DIO (+16g, p<0.001) but not lean rats (+1g, p>0.05) compared to vehicle. In DIO rats, ODT8-SST reduced ambulatory (-27%/24h, p<0.05) and fine movements (-38%, p<0.01) which was associated with an increased positive energy balance compared to vehicle (+50g, p<0.01). Chronic central somatostatin receptor activation in lean rats reduces body weight gain and lean mass independently of food intake which is likely related to growth hormone inhibition. In DIO rats, ODT8-SST reduces lean mass but promotes food intake and fat mass, indicating differential responsiveness to somatostatin under obese conditions.
authors.affiliation: Department of Medicine, CURE Digestive Diseases Research Center, Center for Neurobiology of Stress, Digestive Diseases Division UCLA, and VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA.
authors.forename: Andreas
authors.initials: A
authors.lastname: Stengel
authors.forename: Tamer
authors.initials: T
authors.lastname: Coskun
authors.forename: Miriam
authors.initials: M
authors.lastname: Goebel-Stengel
authors.forename: Libbey S
authors.initials: LS
authors.lastname: Craft
authors.forename: Jorge
authors.initials: J
authors.lastname: Alsina-Fernandez
authors.forename: Lixin
authors.initials: L
authors.lastname: Wang
authors.forename: Jean
authors.initials: J
authors.lastname: Rivier
authors.forename: Yvette
authors.initials: Y
authors.lastname: Taché
mesh_terms: D000818:Animals; D001835:Body Weight / Q000187:drug effects*; D004032:Diet; D004435:Eating / Q000187:drug effects*; D007267:Injections; D008297:Male; D009765:Obesity / Q000209:etiology / Q000378:metabolism; D010446:Peptide Fragments / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D017481:Receptors, Somatostatin / Q000378:metabolism; D013004:Somatostatin / Q000008:administration & dosage / Q000819:agonists* / Q000031:analogs & derivatives* / Q000494:pharmacology; D013851:Thinness / Q000378:metabolism; D015430:Weight Gain / Q000187:drug effects*
chemical_list: D010446:Peptide Fragments; D017481:Receptors, Somatostatin; D013004:Somatostatin; C017583:somatostatin, octapeptide-Trp(8)-